Seattle, WA, United States of America

Marcos E Milla

This inventor holds 2 USPTO granted patents. Top assignee: Adaptive Biotechnologies Corporation. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcos E Milla. Retrieved from https://idiyas.com/inventor/marcos-e-milla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Marcos E Milla: Pioneering T Cell Receptor Technology

Introduction

Marcos E Milla is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of immunology, particularly in the development of methods for determining antigen-specific T cells. His work is crucial for advancing cancer therapies and understanding immune responses.

Latest Patents

Marcos E Milla holds a patent for "Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)." This invention focuses on methods for identifying antigen-specific T cells and T cell receptors that bind to the Wilms' tumor antigen-1 (WT1) protein. The patent also includes polynucleotides encoding the TCRs, engineered cells that express these TCRs, and methods for their production and application. He has 1 patent to his name.

Career Highlights

Marcos E Milla is associated with Adaptive Biotechnologies Corporation, a company known for its innovative approaches in the field of biotechnology. His work at the company has positioned him as a key player in the development of T cell receptor technologies.

Collaborations

Marcos has collaborated with notable colleagues, including Edward J Osborne and Joyce K Hu. These partnerships have further enhanced the research and development efforts in the field of T cell therapies.

Conclusion

Marcos E Milla's contributions to T cell receptor technology represent a significant advancement in immunology. His innovative work continues to pave the way for new therapeutic strategies in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…